Lead Discovery of Type II BRAF V600E Inhibitors Targeting the Structurally Validated DFG-Out Conformation Based Upon Selected Fragments
Molecules - Switzerland
doi 10.3390/molecules21070879
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 16, 2016
Authors
Publisher
MDPI AG